Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2004
04/08/2004WO2004029287A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
04/08/2004WO2004029286A2 Method for identifying the enzyme activities of any protein extract
04/08/2004WO2004029284A2 Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes
04/08/2004WO2004029283A2 Subtelomeric dna probes and method of producing the same
04/08/2004WO2004029281A2 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals
04/08/2004WO2004029258A1 Nucleic acid constructs for gene expression
04/08/2004WO2004029251A1 Fructosylamine oxidase
04/08/2004WO2004029244A1 Animal cells having chimeric receptor and utilization thereof
04/08/2004WO2004029243A1 Method of predicting genetic risk for hypertension
04/08/2004WO2004029241A1 Method of amplifying nucleic acid by electromagnetic induction heating and reaction container and reaction device to be used therein
04/08/2004WO2004029239A1 Crystal structure of chorismate synthase and uses thereof
04/08/2004WO2004029225A2 Detection of modular polyketide synthase gene clusters
04/08/2004WO2004029216A2 Diagnosis of invasive mold infection
04/08/2004WO2004029196A2 Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith
04/08/2004WO2004029084A2 Lipase inhibitors and uses thereof
04/08/2004WO2004029023A2 Cell-surface estrogen receptor and related compositions and methods
04/08/2004WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis
04/08/2004WO2004028478A2 Functional mutations in respiratory syncytial virus
04/08/2004WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
04/08/2004WO2004028464A2 Methods and compositions for modification of splicing of pre-mrna
04/08/2004WO2004028458A2 Antisense modulation of microsomal prostaglandin e2 synthase expression
04/08/2004WO2004028352A2 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
04/08/2004WO2004028346A2 Detection methods
04/08/2004WO2004028341A2 Susceptibility gene for human stroke; methods of treatment
04/08/2004WO2004013607A3 Methods, devices and kits for multiplex blotting of biological samples from multi-well plates
04/08/2004WO2004013351A3 Target dna
04/08/2004WO2004013348A3 Method for determining endoglycosidase enzyme activity
04/08/2004WO2004012658A3 Method and device for protein delivery into cells
04/08/2004WO2004011675A3 Novel allelic variants in the factor vii gene
04/08/2004WO2004011637A3 Modified adamts4 molecules and method of use thereof
04/08/2004WO2004011596A3 Method for preparing an extracellular matrix and its use for tumor cell culture
04/08/2004WO2004011401A3 Method for making biochips
04/08/2004WO2004010537A3 Flexible biochip
04/08/2004WO2004009839A3 Oligonucleotides for detecting micro-organisms
04/08/2004WO2004009497A3 Method of monitoring biofouling in membrane separation systems
04/08/2004WO2004008144A3 Method capable of being automated for detection of prpres and uses thereof
04/08/2004WO2004007764A3 Chromosome 3, 5 and 11 genes involved in premature canities
04/08/2004WO2004007692A3 Methods and compositions for analyzing polymers using chimeric tags
04/08/2004WO2004006985A3 Assaying and imaging system identifying traits of biological specimens
04/08/2004WO2004003139A3 Modified shine-dalgarno sequences and methods of use thereof
04/08/2004WO2004002294A3 Plasma or serum marker and process for detection of cancer
04/08/2004WO2004001069A3 Compositions and methods for detecting pathologies affecting neuromuscular transmission
04/08/2004WO2004001004A3 Membrane associated tumor endothelium markers
04/08/2004WO2004000096A3 Novel bartonella antigen lysate extracts for use in elisa diagnostic
04/08/2004WO2003107144A3 Systems and methods for predicting oligonucleotide melting temperatures (tms)
04/08/2004WO2003106684A3 A method for simultaneous production of multiple proteins; vectors and cells for use therein
04/08/2004WO2003106620A3 Nucleic acid sequencing by signal stretching and data integration
04/08/2004WO2003104490A3 Method for the simultaneous detection of hybridization and vaccination reactions
04/08/2004WO2003104487A3 Detection of epigenetic abnormalities and diagnostic method based thereon
04/08/2004WO2003102578B1 High throughput cellular response assay using microarrays
04/08/2004WO2003100090A3 Protein c polymorphisms
04/08/2004WO2003100087A3 Regulation of novel human asparagine-hydroxylases
04/08/2004WO2003098184A3 Method for identifying modulators of sulfotransferase activity
04/08/2004WO2003095976A3 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
04/08/2004WO2003095664A3 Pyrophosphorolysis activated polymerization (pap)
04/08/2004WO2003091701A3 Implantable biosensor from stratified nanostructured membranes
04/08/2004WO2003087297A8 Infectious disease microarray
04/08/2004WO2003087021A3 Nanoparticle delivery systems and methods of use thereof
04/08/2004WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
04/08/2004WO2003080857A3 Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis
04/08/2004WO2003076610A3 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
04/08/2004WO2003072823A3 Method for in vitro detection of cancers by highlighting allelic imbalances in insertion/deletion markers
04/08/2004WO2003072820A3 Method and nucleic acids for the analysis of colon cell proliferative disorders
04/08/2004WO2003070974A3 Mismatch repair detection
04/08/2004WO2003066900A3 Eif4e gene mutations and potyvirus resistance
04/08/2004WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
04/08/2004WO2003065006A3 Methods and compositions for treating cancer
04/08/2004WO2003064469A3 Regulation of human hematopoietin receptor-like protein
04/08/2004WO2003064468A3 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
04/08/2004WO2003063893A3 Fgfr agonists
04/08/2004WO2003062466A3 Method of detecting a strain of staphylococcus aureus
04/08/2004WO2003056336A3 Improved structured-functional bonding matrices for biomolecules
04/08/2004WO2003054225A3 Method for determining nucleic acid analytes
04/08/2004WO2003048385A3 Oligonucleotide array, nucleotide detection method and device therefor
04/08/2004WO2003046581A3 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers
04/08/2004WO2003042409A8 Germ line mutation in the promoter of e-caderine and diagnostic method for finding a greater susceptibility to gastric carcinoma
04/08/2004WO2003033646A8 Compositions and methods for the modulation of viral maturation
04/08/2004WO2003022123A9 Methods of kidney transplantation utilizing developing nephric tissue
04/08/2004WO2003020978B1 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group
04/08/2004WO2003017177A3 Method and system for profiling biological systems
04/08/2004WO2003016894A3 Coplanar waveguide biosensor for detecting molecular or cellular events
04/08/2004WO2003014382A8 Device for analyzing nucleic acid
04/08/2004WO2003014300A3 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
04/08/2004WO2003012030A3 Isoform-selective inhibitors and activators of pde3 cyclic
04/08/2004WO2003007699A3 Transcription factors of cereals
04/08/2004WO2003001968A8 Compositions and methods for inhibiting platelet activation and thrombosis
04/08/2004WO2002099385A3 Qtl controlling sclerotinia stem rot resistance in soybean
04/08/2004WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use
04/08/2004WO2002097058A3 Genetic markers for improved disease resistance in animals (nramp1)
04/08/2004WO2002074992A3 Phosphodiesterase 4d genes related to human stroke
04/08/2004WO2002073154A3 Method and the detection of bacteria and bacterial groups
04/08/2004WO2002072541A3 Human grk7: new member of the human g-protein-coupled-receptor kinase family
04/08/2004WO2002061661A3 Methods for determining protein and peptide terminal sequences
04/08/2004WO2002058546A3 Methods for screening for substances which inhibit fp prostanoid receptor
04/08/2004WO2002053712A9 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e
04/08/2004WO2002048402A3 Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
04/08/2004WO2002044319A3 Spatially directed ejection of cells from a carrier fluid
04/08/2004WO2002029104A8 Tumor marker and methods of use
04/08/2004WO2002015107A3 Basecalling system and protocol
04/08/2004WO2000075276A3 Dna detector based on molecular controlled semiconductor resistor